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Vitronectin is a multifunctional glycoprotein known to be 
associated with the dermal elastic fiber network in human 
adults, with various types of human amyloid and with apop-
to tic keratin bodies in human skin. It has also been shown to 
bind to human keratin intermediate filaments and to intranu-
clear material in vitro. 
To learn more of its function and mode of tissue deposi-
tion, vitronectin in mouse skin was studied. Vitronectin was 
purified from mouse plasma and a polyclonal anti-vitronectin 
antiserum was produced. This was used in an avidin-biotin-
peroxidase complex technique and in an immunofluores-
cence technique on biopsy sections of dorsal skin from mice. 
Hairless lightly pigmented mice, known to develop dermal 
amyloid deposits at advanced ages, were used, making it possi-
ble to study vitronectin's association not only with elastic 
fibers but also with amyloid. Association of vitronectin with 
V itronectin, also called serum-spreading factor and S protein, is a glycoprotein present in plasma and tissue ll-3]. The tissue form of human vitronectin has been demonstrated to occur in association with elastin, with apoptotic cells, and with amyloid and sclerotic 
lesions [4 - 7] . 
Several properties of vitronectin have been demonstrated [1,8,9] . 
It has an Arg-Gly-Asp-containing binding site for surface receptors 
belonging to the integrin family of receptors present on several 
types of cells, e.g., macrophages, thrombocytes, and endothelial 
cells [2,3,10-12]. It can also act as an inhibitor to the membrane 
attack complex of complement [1,8]. However, the function of 
vitronectin is not yet clear. The finding that phagocytosis of apop-
totic leucocytes was dependent on the vitronectin receptor of macro-
phages suggested that vitronectin might function as a scavenger 
protein [13] . Its presence in conjunction with amyloid, elastotic, and 
sclerotic material, and with keratin bodies, may hypothetically en-
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elastotic material was investigated in mice exposed to ultravi-
olet radiation. 
No vitronectin immunoreactivity could be demonstrated 
in association with elastin-stained material in skin specimens 
from any of the mice, whether exposed to ultraviolet radia-
tion or not. In contrast, vitronectin was constantly found to 
be associated with dermal amyloid deposits . Moreover, 
mouse vitronectin was found to bind to mouse keratinocytes 
when studied by immunofluorescence staining of skin sec-
tions that had been pre-incubated with mouse plasma as 
sources of vitronectin. The results indicate that vitronectin is 
associated with amyloid and can bind to intracellular struc-
tures in epidermal keratinocytes in mice as in humans, and 
that mouse tissue may be used for the study of vitronectin's 
interactions with amyloid and with intracellular structures. 
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hance macrophage rhagocytosis of these different types of degener-
ative material [5 - 7 . In immunohistochemical studies using human 
anti-vitronectin antibodies after pre-incubation with serum as a 
source of vitronectin, vitronectin was shown to bind to cytoplasmic 
structures of human epidermal keratinocytes, and to the cytoskele-
ton and nucleoli of Hep 2 cells [14]. Binding of vitronectin to 
isolated keratin intermediate filaments has also been reported [14]. 
These findings suggested that vitronectin might be involved in the 
removal of extracellular cytoskeleton and nuclear material. 
In a study of different age groups, vitronectin was found in con-
junction with the dermal elastic fiber network in adults but not in 
the young, indicating that it is deposited on such fibers during late 
childhood [5]. Ultrastructurally, vitronectin immunoreactivity is 
localized to the periphery of the elastic fibers. Immunohistochemi-
cal studies, comparing the dermal distributions of vitronectin, elas-
tin, and a major constituent of elastic fiber microfibrils, fibrillin , 
indicate that vitronectin associates with elastin rather than with the 
elastin-associated microfibrils [15]. Tissue vitronectin is non-cova-
lently bound to dermal elastic fibers [16]. Comparison of the distri-
butions of vitronectin and complement factor 9 (C9) in human skin 
suggested that the deposited vitronectin is not generally complexed 
with C9 [5]. C9 was found to be associated with elastin-stained 
material only in sun-exposed skin of older individuals, though no 
correlation of vitronectin deposition and ultraviolet (UV) radiation 
was demonstrated [5]. 
In this study, designed to improve our understanding of the func-
tion of tissue vitronectin and its mode of deposition, the distribution 
of vitronectin in mouse skin was studied. The animals used are 
known to develop age-related generalized amyloidosis with dermal 
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amyloid deposits, making it possible to study the association of 
vitronectin not only with elastin but also with amyloid in the dermis 
[17] . The ability of human and mouse vitronectin to bind to struc-
rures in skin was also investigated. 
MATERIALS AND METHODS 
Biologic Material Skin biopsies were obtained from the dorsa of 
48 hairless, lightly pigmented mice (hr/hr C3H Tif, from Bom-
holdt-gaard, Denmark). The animals were 13 months old at the 
time of biopsy. Twenty-four of the animals were irradiated with 
UVB (Philips TL12 tubes) 5 min per day four times a week for 12 
weeks prior to biopsy. The intensity was 1.42 mW /cm2 corre-
sponding to 5 B-MED (basic minimal erythema dose) per treatment 
(total 20.5 J /cm2 - 250 B-MED). Another 24 mice were not ex-
posed to UV radiation. 
Human sera were obtained from normal volunteers and were 
stored at -20°C until used. Normal human skin was obtained as 
trirnrnings from excision biopsies. . 
Proteins and Antisera Vitronectin was purified from mouse 
plasma using the method described by Yathogo and co-workers, and 
a polyclonal anti-mouse vitronectin antiserum was produced in rab-
bits [18]. When tested against mouse plasma with immune electro-
phoresis, the antiserum demonstrated only a single precipitin line, 
corresponding with the precipitin line obtained when the antiserum 
was run against purified mouse vitronectin. Amino-terminal amino 
acid sequences were determined with a gas-phase sequenator (Ap-
plied Biosystems Model 4 70A) as previously described [19]. Purified 
vitronectin was subjected to polyacrylamide gel electrophoresis in 
the presence of sodium dodecylsulfate and then transferred to Im-
mobilon membranes. The vitronectin was detected by Coomassie 
staining, and the membrane piece containing the major 65-kDa 
band was cut out and put in the sequenator as described by Matsu-
daira [20]. Two amino acids were obtained in each step (in approxi-
mately equal amounts), suggesting the presence of two sequences. 
Eighteen cycles were performed and the following amino acids 
were observed in cycles 1-18: 1, Asp and Ala; 2, Asp and Gin; 3, Gin 
and Glu; 4, Glu and Ser; 5, Ser, and -; 6, Lys and -; 7, Lys and Gly; 8, 
Gly and Arg; 9, Arg and -; 10, Thr and -; 11, Thr and Gin; 12, Gin 
and Gly; 13, Gly and Phe; 14, Phe and Met; 15, Metand Ala; 16, Ala 
and Ser; 17, Ser and Lys; 18, Lys. It is obvious that the two sequences 
represent the same protein, and that one sequence begins on the 
second residue of the other. Thus, the longer of the two sequences 
was Ala-Asp-Gln-Glu-Ser-Xxx-Lys-Gly-Arg-Xxx-Thr-Gln-Gly-
Phe-Met-Ala-Ser-Lys, and the shorter started with Asp in the sec-
ond position. The sequence is very similar to that of human vitro-
nectin, and identical to the reported sequence of mouse vitronectin 
determined by eDNA cloning [2,3,21J. The Xxx corresponds to 
Cys residues that were not detectable as the analyzed protein was 
unreduced. The results show that the amino-terminus of mouse 
vitronectin is heterogeneous, and that approximately 50% of vi-
tronectin in plasma is one amino acid longer than the other 50%. 
The heterogeneity of the amino-terminus may be due to alternative 
cleavages by the signal peptidase. In a report describing the eDNA 
cloning of mouse vitronectin, the amino-terminus of the mature 
vitronectin was suggested to be Asp, which is in the second position 
in the longer of the two sequences we observed [21]. 
The working dilution of the anti-mouse vitronectin antiserum 
was 1: 5000 (avidin-biotin-peroxidase complex technique) or 
1: 300 (immunofluorescence technique). Polyclonal anti-human 
vitronectin, previously characterized, was used in a working dilu-
tion of 1 : 10,000 (avidin-biotin-peroxidase complex technique) or 
1: 800 (immunofluorescence technique) [4]. 
Irnm.unohistochemical Techniques The avidin-biotin-perox-
idase complex technique used was that described by HSll and co-
workers [22]. A standard immunofluorescence technique was also 
used (see below). 
Histochemical Stain Orcein was used in a standard elastin-
staining procedure [23]. Orcein staining corresponds with immuno-
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staining using a monoclonal anti-elastin antibody (unpublished re-
sults). Congo red was used to stain amyloid in sections of the skin. 
The congophilic amyloid deposits showed green birefringence 
when analyzed in polarized light. 
Immunofluorescence Examination of Binding of Vitronec-
tin to Skin Cryostat sections of normal human skin, normal 
mouse skin, and UV -exposed mouse skin were incubated either 
with normal human plasma or with normal mouse serum (the sera 
being used as sources of vitronectin) for 30 min at room tempera-
ture. The substrates were then washed extensively. The presence or 
absence of binding of vitronectin was determined by immunofluo-
rescence staining using polyclonal anti - human vitronectin and 
polyclonal anti - mouse vitronectin. 
RESULTS 
Vitronectin Immunoreactivity in Mouse Skin Thin orcein-
stainable elastic fibers were present in all skin specimens from the 
mice that were not exposed to UV radiation (Fig la) as they were in 
all skin specimens from UV -exposed animals. The elastic fibers in 
the specimens from UV-exposed mice were often irregular and 
sometimes thicker than those in mice unexposed to UV radiation 
(Fig 2a). 
Amyloid deposits were present in all the specimens (Figs le and 
2e), those 111 non-irradiated mice being present in a thin zone under 
the epidermis (le) and those in the UV-exposed skin specimens 
occupying a broader zone in the dermis (2e). The anti-mouse vi-
tronectin antibodies consisten~ly immunostained the amyloid depos-
Its (Figs Ib and 2b) . The anti-human vitronectin antibodies also 
immunostained amyloid in mouse skin, although the staining was 
faint (not shown). 
In contrast, no vitronectin immunoreactivity could be detected in 
conjunction with elastic fibers in skin specimens from any of the 
mice, irrespective of whether anti - mouse vitronectin antibodies or 
anti-human vitronectin antibodies were used (Figs Ib and 2b). 
Immunofluorescence Examination of Binding of Vitronec-
tin to Skin Immunoreactivity of mouse vitronectin was seen in 
the keratinocytes of mouse skin after incubation with mouse plasma 
(Fig 3a), and immunoreactivity of human vitronectin was seen in 
the keratinocytes in human skin after incubation with human serum 
(Fig 3e). Mouse and human vitronectin differed somewhat in the 
distribution of binding to the respective keratinocytes, the human 
vitronectin being localized more peripherally in the cells than the 
mouse vitronectin. However, it was not possible to determine the 
nature of the vitronectin binding intracellular structures with the 
light-microscopy method used. 
DISCUSSION 
No vitronectin immunostaining of dermal elastic fibers in mice 
could be detected in this study, a finding in contrast to the distinct 
vitronectin immunoreactivity found in conjunction with dermal 
elastic fibers in human adult individuals found in an earlier study [5]. 
The age of the mice used in this study was 13 months. The normal 
li fe span of these mice is 2 years. In the earlier age-group study on 
vitronectin in human skin, no vitronectin immunoreactivity was 
found on elastic fibers in specimens from children under four years 
of age. Thus, eve~ though the mice now studied were fully grown, 
their dermal elastic fiber networks have existed for only a relatively 
short time, perhaps too short for vitronectin to be deposited or for a 
sufficient amount of deposited vitronectin to be detectable with the 
immunohistochemical method. The turnover of elastin is consid-
ered to be very slow and the immunohistochemical demonstration 
of vitronectin in conjunction with elastic-tissue may be a phenome-
non occurring in species with relatively long life spans. 
In accord with findings in our earlier study on human skin, 
no evidence was found in the present study to indicate that UV 
irradiation increases the deposition of vitronectin on dermal elastic 
fibers [5]. 
The present results confirm those of an earlier study in which 
dermal amyloid was found to be present in the papillary derrnis of 
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Figure 1. Vitronectin immunoreactivity associated with amyloid but not 
with elastic fibers in mouse skin , unexposed to UV radiation. Consecutive 
sections of dorsal skin biopsies from a hairless mouse, unexposed to UV 
radiation, (hr/hr C3H Tif), 13 months old, stained with orcein elastin 
staining (a), immunostained with polyclonal anti-vitronectin in an av idin 
biotin peroxidase complex technique (b), and stained with congo red ana-
lyzed in polarized light (e) . Bar, 50/-lm. 
b 
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Figure 2. Vitronectin immunoreactivity associated with amyloid but not 
with elastic fibers in mouse skin, exposed to UV radiation. Consecutive 
sections of dorsal skin biopsies from a UVB-irradiated hairless mouse (hr/hr 
C3H Tif) , 13 months old, stained with orcein elastin staining (a), irnmun-
ostained with polyclonal anti-vitronectin in an avidin-biotin-peroxidase 
complex technique (b), and stained with congo red analyzed in polarized 
light (e) . Bar, 50/-lm. 
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hairless lightly pigmented mice (hr/hr C3H Tif) of high age [17]. 
Amyloid is also present in the internal organs of these mice [17]. 
The primary rrotein of this amyloid is unknown. The histologic 
localization 0 amyloid in the non-UV irradiated mice is similar to 
that of primary cutaneous localized amyloid in humans [24]. The 
cutaneous amyloid deposition was earlier found to be related with 
advanced age of the mice rather than to UV radiation exposure. In 
this study the dermal amyloid deposits in the skin of the UV-irra-
Figure 3. Binding of mouse and human vitronectin to keratinocytes ill vitro. 
Sections of mouse skin incubated with mouse plasma (aJ or buffer (b) and 
immunostained with polyclonal anti-mouse vitronectin antibodies in an 
immunofluorescence technique and sections of human skin incubated with 
human serum (c) or buffer (d) and immunostained with anti-human vi-
rronectin antibodies in an immunofluorescence technique. Note staining of 
the keratinocytes of sections incubated with plasma as a source of vitronectin 
(a and c). whereas there is no staining of the keratinocytes of control sections 
incubated with buffer only (b and d) . Human elastic fibers immunostained 
with anti-vitronectin are present in the upper part of a dermal papilla seen in 
the lower right corner of d. Bar. 50 jim. 
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diated animals extended further down into the dermis than in non-
UV-exposed animals, and the area of the amyloid deposits was 
larger (Figs 2b,c). However, the question whether the amount of 
amyloid is actually increased as an effect ofUV radiation needs to be 
resolved with biochemical techniques that are also needed for the 
identification of the primary protein of this age-related mouse amy-
loidosis. In this context, the results of a study on psoralen + UV A 
(PUVA)-treated psoriasis patients are of interest: depositions macro-
scopically similar to amyloid and to keratin bodies were found to be 
deposited in the papillary dermis after PUV A treatment; ultrastruc-
turally this material manifested properties both of keratin bodies 
and amyloid [25]. 
Vitronectin immunoreactivity has been found in association with 
several types of human amyloid, and the findings of vitronectin 
immunoreactivity in conjunction with cutaneous mouse amyloid 
deposits reported here indicate binding of vitronectin to amyloid to 
be a general phenomenon. The results obtained using the newly 
produced anti-mouse vitronectin antiserum were confirmed by the 
use of the specific polyclonal anti - human vitronectin antiserum, 
which showed slight crossreactivity with mouse vitronectin in 
amyloid. 
The function of vitronectin in association with amyloid is un-
clear. However, in view of earlier reports suggesting that vitronec-
tin may act as a scavenger protein, it might be hypothesized that 
amyloid-associated vitronectinmay act as an opsonin-augmenting 
phagocytosIs of the degenerative materIal [13J. Likewise, it may 
have a role to augment phagocytosis of old and/or altered elastin. 
Vitronectin has been found to be associated not only with elastin 
and amyloid, but also with such degenerative material as sclerotic 
materia~ and with keratin bodies that are regarded as fragments of 
apoptotIc keratmocytes mamly composed of keratin intermediate 
filaments [26]. The binding of mouse and human vitronectin to 
intracellular structures in keratinocytes found in the present study 
suggests that this property of vitronectin may be of importance for 
the elimination process of cellular debris, e.g., cytoskeleton and 
DNA, during normal cell turnover. 
The present findings of an association of vitronectin with cutane-
ous mouse amyloid and of the binding of vitronectin to intracellular 
structures in mouse keratinocytes may form the basis for further 
studies of the interactions between vitronectin, degenerative mate-
rial, and phagocytotic cells using a mouse model. 
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